рдпрд╣ рд╡реАрдбрд┐рдпреЛ +18 . рд╕реЗ рдХрдо рдЙрдореНрд░ рдХреЗ рджрд░реНрд╢рдХреЛрдВ рдХреЗ рд▓рд┐рдП рдкреНрд░рддрд┐рдмрдВрдзрд┐рдд рд╣реИ

рдЕрдкрдиреА рдЙрдореНрд░ рдХреА рдкреБрд╖реНрдЯрд┐ рдХрд░рдиреЗ рдХреЗ рд▓рд┐рдП рдПрдХ рдЦрд╛рддрд╛ рдмрдирд╛рдПрдВ рдпрд╛ рд▓реЙрдЧрд┐рди рдХрд░реЗрдВред

194 | Science and Business Synergy | Filling Gaps with AI | Entrepreneurial Path | Ethical and Commercial Balance | Andrew Stelzer from Unlearn.ai

0 рд╡рд┐рдЪрд╛рд░реЛрдВ┬╖ 09/21/23
Failing to Success
Failing to Success
0 рдЧреНрд░рд╛рд╣рдХреЛрдВ
0
рдореЗрдВ

ЁЯЪА Key Talking Points:ЁЯзк Science and Business Synergy: Andrew Stelzer's transition from being a scientist to a key player in business development at Unlearn.Ai showcases the valuable intersection between science and entrepreneurship, driving innovation for the future of medicine.ЁЯТб Filling Gaps with AI: AI-driven clinical outcome predictions bring potential for more efficient drug trials, minimizing participants' risk, and expediting approval processes, thereby revolutionizing pharmaceutical and biotech industries.ЁЯЪА Entrepreneurial Path: Stelzer's journey exemplifies the power of embracing uncertainty and charting new territories in startups, creating from scratch, and finding fulfillment through driving the growth of a company.ЁЯМН Ethical and Commercial Balance: The ethical implications of human testing in drug approval are highlighted, as AI advancements offer a chance to enhance clinical trial efficiency while minimizing risks.ЁЯУЪ Science and Business Integration: Stelzer's advice for scientists stresses a holistic approach – understanding both the science and business landscapes, seeking mentorship, and daring to transform research into tangible solutions.тЮбя╕П Book a Call with ChadЁЯУЭ Episode Summary:In this episode 188 of "Failing to Success" , Andrew Stelzer's transformation from a biophysicist into a business development leader at Unlearn.Ai embodies the synergy between science and entrepreneurship. His journey through academia and industry showcases how AI-driven clinical outcome predictions can revolutionize pharmaceutical trials by reducing participants' risk and speeding up approval processes. Stelzer's choice to join a startup reflects his passion for innovation and building from scratch, emphasizing the entrepreneurial spirit. The discussion delves into the ethical considerations of medical experimentation and highlights the importance of understanding both science and business for successful innovation.SUBSCRIBE TO THE PODCAST ON YOUTUBEListen on:APPLE PODCASTS‍SPOTIFY‍CASTBOX‍PODCAST ADDICTGOOGLE PODCASTS‍Add us on:INSTAGRAMTIKTOKTWITTERLINKEDINScience and Business Synergy, AI in Medicine, Startup Journey, Clinical Trial Innovation, Ethical Considerations in Medical Research, Entrepreneurial Pa

рдФрд░ рджрд┐рдЦрд╛рдУ

 0 рдЯрд┐рдкреНрдкрдгрд┐рдпрд╛рдБ sort   рдЗрд╕рдХреЗ рдЕрдиреБрд╕рд╛рд░ рдХреНрд░рдордмрджреНрдз рдХрд░реЗрдВ


рдЕрдЧрд▓рд╛